Effects of Antiviral Therapy on Long-term Reoccurrence Rate after Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-13004570

Enrollment

Unknown

Registered

2013-12-10

Start date

2013-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B virus –related hepatocellular carcinoma

Interventions

Treatment group:Antiviral Treatment

Control group:no

Eligibility

Sex/Gender

All

Age

14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. hepatitis B virus(HBV)-related hepatocellular carcinoma; 2. child-pugh grade A or grade B.

Exclusion criteria

Exclusion criteria: 1. negative test for HbsAg; 2. evidence of co-infection with other hepatotropic viruses; 3. child-pugh grade C; 4. Any other malignancy; 5. with a history of discontinuation or poor complicance in taking anti-viral medications; 6. With cancer embolus in vessel.

Design outcomes

Primary

Measure	Time frame
long- term survival rate;recurrence rate;	—

Secondary

Measure	Time frame
IL-6;vitaminD;HBeAg positive;the level of serum HBV-DNA;	—

Countries

China

Contacts

Public ContactHong Wu

Department of liver Surgery, West China Hospital, Sichuan University

wuhonghuaxi@163.com+86 18980601958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026